Identification of a 30 kDa antigen from Leishmania (L.) chagasi amastigotes implicated in protective cellular reponses in a murine model

International Journal for Parasitology

Volumn 30, Issue 5, 2000, Pages 599-607

  Pinto, Aguinaldo Roberto ^a,b   Beyrodt, Carolina Guilherme Prestes ^a   Lopes, Renato Antonio Migliano ^a   Barbiéri, Clara Lúcia ^a  

^a Imunologia Parasitol Esc P   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

Amastigotes; Antigens; Leishmania; Leishmania (L.) chagasi; Lymphoproliferation; Protective responses

Indexed keywords

ADJUVANT; ANTIGEN; CORYNEBACTERIUM PARVUM EXTRACT; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2;

ACTIVE IMMUNIZATION; AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; LEISHMANIA CHAGASI; LEISHMANIASIS; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; ANTIGENS, PROTOZOAN; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HOST-PARASITE RELATIONS; LEISHMANIA; MICE; MICE, INBRED BALB C; MOLECULAR WEIGHT; TH1 CELLS;

ANIMALIA; CORYNEBACTERIUM PARVUM; LEISHMANIA AMAZONENSIS; LEISHMANIA DONOVANI CHAGASI; MURINAE;

EID: 0034655633     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(00)00037-0     Document Type: Article

References (43)

1. Adler S. Leishmania. Adv. Parasitol. 2:1964;35-96.
2. Badaró R., Jones T.C., Lorenço R., et al. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J. Infect. Dis. 154:1986;639-649.
3. Evans T.G., Teixeira M.J., McAuliffe I.T., et al. Epidemiology of visceral leishmaniasis in northeast Brazil. J. Infect. Dis. 166:1992;1124-1132.
4. Boom W.H., Leibster L., Abbas A.K., Titus R.G. Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect. Immun. 58:1990;3863-3870.
5. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., Locksley R.M. Reciprocal expression of IFN-γ or IL-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:1989;59-72.
6. + T-cell subsets in the regulation of parasitic immunity and disease. Immunol. Rev. 112:1989;161-182.
7. Carvalho E.M., Barral A., Pedral-Sampaio D., et al. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J. Infect. Dis. 165:1992;535-540.
8. Kaye P.M., Curry A.J., Blackwell J.M. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146:1991;2763-2770.
9. Murray H.W. Effect of continuous administration of interferon-γ in experimental visceral leishmaniasis. J. Infect. Dis. 161:1990;992-994.
10. Murray H.W., Stern J.J., Welte K., Rubin B.Y., Carriero S.M., Nathan C.F. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-γ, tissue reaction, and response to treatment with interleukin 2 and interferon-γ J. Immunol. 138:1987;2290-2297.
11. Squires K.E., Schreiber R.D., McElraith M.J., Rubin B.Y., Anderson S.L., Murray H.W. Experimental visceral leishmaniasis: role of endogenous IFN-γ in host defense and tissue granulomatous response. J. Immunol. 143:1989;4244-4249.
12. Wilson M.E., Young B.M., Andersen K.P., et al. A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice. Inf. Immun. 63:1995;2062-2069.
13. Murray H.W., Hariprashad J. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:1995;387-391.
14. Champsi J., McMahon-Pratt D. Membrane glycoprotein M-2 protects against Leishmania amazonensis infection. Inf. Immun. 56:1988;3272-3279.
15. Handman E., Mitchell G.F. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. Proc. Natl. Acad. Sci. USA. 82:1985;5910-5914.
16. Russell D.G., Alexander J. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol. 140:1988;1274-1279.
17. Scott P., Pearce E., Natovitz P., Sher A. Vaccination against cutaneous leishmanisis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract. J. Immunol. 39:1987;3118-3125.
18. Jaffe C.L., Rachamim N., Sarfstein R. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis. J. Immunol. 144:1990;699-706.
19. White A.C., McMahon-Pratt D. Prophylactic immunization against experimental Leishmania donovani infection by use of a purified protein vaccine. J. Infect. Dis. 161:1990;1313-1314.
20. Barbiéri C.L., Doine A.I., Freymüller E. Lysosomal depletion in macrophages from spleen and foot lesions of Leishmania-infected hamster. Exp. Parasitol. 71:1990;218-228.
21. Gillis S., Ferm M.M., Ou W., Smith K.A. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:1978;2027-2032.
22. Stauber L.A., Franchino E.M., Grun J. An eight-day method for screening compounds against Leishmania donovani in the golden hamster. J. Protozool. 5:1958;269-273.
23. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
24. Beyrodt C.G.P., Pinto A.R., Freymüller E., Barbiéri C.L. Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model. Inf. Immun. 65:1997;2052-2059.
25. Robertson C.D., Coombs G.H. Characterization of three groups of cysteine proteinases in the amastigotes of Leishmania mexicana mexicana. Mol. Biochem. Parasitol. 42:1990;269-276.
26. Jeronimo S.M.B., Higgs E., Vedvick T., et al. Identification of Leishmania chagasi antigens recognized by o induction of protective immunity against fatal Leishmania major infection. J. Immunol. 135:1985;2095-2101.
27. Reed S.G., Carvalho E.M., Sherbert C.H., et al. In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease. J. Clin. Invest. 85:1990;690-696.
28. Howard J.G., Liew F.Y., Hale C., Nicklin S. Prophylatic immunization against experimental leishmaniasis. II - Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes. J. Immunol. 132:1984;450-455.
29. Liew F.Y., Hale C., Howard J.G. Prophylatic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection. J. Immunol. 135:1985;2095-2101.
30. McGurn M., Boon T., Louis J.Á., Titus R.G. Leishmania major: nature of immunity induced by immunization with a mutagenized avirulent clone of the parasite in mice. Exp. Parasitol. 71:1990;81-89.
31. Monjour L., Vouldoukis B., Ogunkolade B., Hetzel C., Ichen M., Frommel D. Vaccination and treatment trials against murine leishmaniasis with semi-purified Leishmania antigens. Trans. R. Soc. Trop. Med. Hyg. 82:1988;412-415.
32. Scott P., Caspar P., Sher A. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes. J. Immunol. 144:1990;1075-1079.
33. Soong L., Duboise S.M., Kima P., McMahon-Pratt D. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect. Immun. 63:1995;3559-3566.
34. Leal L., Moss D., Kuhn R., Muller W., Liew F.Y. Interleukin-4 transgenic mice of resistant background are susceptible to L. (L.) major infection. Eur. J. Immunol. 23:1993;566-569.
35. Scott P. The role of Th1 and Th2 cells in experimental cutaneous leishmanisis. Exp. Parasitol. 68:1990;369-372.
36. Murray H.W., Rubin B.Y., Rothermel C.D. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-γ is the activating lymphokine. J. Clin. Invest. 72:1983;1506-1510.
37. Alfieri S.C., Shaw E., Zilberfarb V., Rabinovitch M. Leishmania amazonensis: involvement of cysteine proteinases in the killing of isolated amastigotes by L-leucine methyl ester. Exp. Parasitol. 68:1989;423-431.
38. Coombs G.H. Proteinases of Leishmania mexicana and other flagelate protozoa. Parasitology. 84:1982;149-155.
39. Pupkis M.F., Coombs G.H. Purification and characterization of proteolytic enzymes of Leishmania mexicana mexicana amastigotes and promastigotes. J. Gen. Microbiol. 130:1984;2375-2383.
40. Pupkis M.F., Tetley L., Coombs G.H. Leishmania mexicana: amastigote hydrolases in unusual lysosomes. Exp. Parasitol. 62:1986;29-39.
41. Mottram J.C., Frame M.J., Brooks D.R., et al. The multiple cpb cysteine proteinase gene of Leishmania mexicana encode enzymes that differ in their stage regulation and substrate preferences. J. Biol. Chem. 272:1997;14285-14293.
42. Carvalho E.M., Badaró R., Reed S.G., Johnson W.D., Jones T.C. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Invest. 76:1985;2066-2069.
43. Vinhas V., Freire M., Bacellar O., Cunha S., Rocha H., Carvalho E.M. Characterization of T cell responses to purified Leishmania antigens in subjects infected with Leishamania chagasi. Braz. J. Med. Biol. Res. 27:1994;1199-1205.